(STAT News) – Some of the most hot-button issues in health and medicine will be fought out in courtrooms in 2018. Cases before federal courts and the U.S. Supreme Court this year have the potential to shape health policy in the U.S. for years or decades to come. And, in at least one case, the outcome could set an important precedent for how taxpayers can hold drug manufacturers responsible. Here are three cases to watch.
Theoretical Medicine and Bioethics (vol. 38, no. 5, 2017) is available online by subscription only.
- “Harm and the Concept of Medical Disorder” by Neil Feit
- “If Abortion, then Infanticide” by David B. Hershenov and Rose J. Hershenov
Public Health Ethics (vol. 10, no. 3, 2015) is available online by subscription only.
- “Improving Nonmedical Vaccine Exemption Policies: Three Case Studies” by Mark Christopher Navin and Mark Aaron Largent
- “Out of Alignment? Limitations of the Global Burden of Disease in Assessing the Allocation of Global Health Aid” by Kristin Voigt and Nicholas B King
- “Counter-Manipulation and Health Promotion” by T M Wilkinson
- “Reexamination of the Concept of ‘Health Promotion’ through a Critique of the Japanese Health Promotion Policy” by Taketoshi Okita, Aya Enzo, and Atsushi Asai
- “Stay Out of the Sunbed! Paternalistic Reasons for Restricting the Use of Sunbeds” by Didde Boisen Andersen and Søren Flinch Midtgaard
- “Community-Based Planning and the New Public Health” by John W Murphy and Berkeley Franz
- “Attitudes of Public Health Academics toward Receiving Funds from for-Profit Corporations: A Systematic Review” by Rima T Nakkash, Sanaa Mugharbil, Hala Alaouié, and Rima A Afifi
- “Can We Care for Aging Persons without Worsening Global Inequities? The Case of Long-Term Care Worker Migration from the Anglophone Caribbean” by Jeremy Snyder and Valorie A Crooks
- “Governing Well in Community-Based Research: Lessons from Canada’s HIV Research Sector on Ethics, Publics and the Care of the Self” by Adrian Guta et al.
Medicine, Health Care and Philosophy (vol. 20, no. 4, 2017) is available online by subscription only.
- “Medical Epistemology” by Henk ten Have and Bert Gordijn
- “Rethinking Critical Reflection on Care: Late Modern Uncertainty and the Implications for Care Ethics” by Frans Vosman and Alistair Niemeijer
- “Understanding Patient Needs Without Understanding the Patient: The Need for Complementary Use of Professional Interpreters in End-of-Life Care” by Demi Krystallidou, Ignaas Devisch, Dominique Van de Velde, and Peter Pype
- “The Sensible Health Care Professional: A Care Ethical Perspective on the Role of Caregivers in Emotionally Turbulent Practices” by Vivianne Baur, Inge van Nistelrooij, and Linus Vanlaere
- “Clinical Judgment, Moral Anxiety, and the Limits of Psychiatry” by Bradley Murray
- “Are There Moral Differences Between Maternal Spindle Transfer and Pronuclear Transfer?” by César Palacios-González
- “Necessity and Least Infringement Conditions in Public Health Ethics” by Timothy Allen and Michael J. Selgelid
- “Death and Dignity in Catholic Christian Thought” by Daniel P. Sulmasy
- “Islamic Perspectives on Clinical Intervention Near the End-of-Life: We Can But Must We?” by Aasim I. Padela and Omar Qureshi
- “Ethical Conflicts in the Treatment of Fasting Muslim Patients with Diabetes During Ramadan” by Ilhan Ilkilic and Hakan Ertin
Studies in Christian Ethics (vol. 30, no. 4, 2017) is available online by subscription only.
- “‘Do You Not Know that Your Bodies are Members of Christ?’: Towards a Christian Body Politics and the Cultural Practice of Cosmetic Surgery” by Jason Reimer Greig
- “Fragments of the Body in Christian, Bioethical and Social Imaginaries” by Paul Scherz
Ethics and Behavior (vol. 27, no. 8, 2017) is available online by subscription only.
- “Healthcare at Your Fingertips: The Professional Ethics of Smartphone Health-Monitoring Applications” by Vivian Kwan, Gregory Hagen, Melanie Noel, Keith Dobson, and Keith Yeates
- “Assent and Dissent: Ethical Considerations in Research With Toddlers” by Hallie R. Brown, Elizabeth A. Harvey, Shayl F. Griffith, David H. Arnold, and Richard P. Halgin
- “Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance Between Risks and Benefits” by Melvyn W. Zhang and Roger C. Ho
(ABC News) – The number of women who use marijuana while pregnant is increasing, especially among teenage and young pregnant mothers, a new report in the Journal of the American Medical Association (JAMA) suggested. “Marijuana is the most commonly used illicit drug during pregnancy,” the research letter published in JAMA on Tuesday stated. “And its use is increasing.”
(Vox) – The recent news that stents inserted in patients with heart disease to keep arteries open work no better than a placebo ought to be shocking. Each year, hundreds of thousands of American patients receive stents for the relief of chest pain, and the cost of the procedure ranges from $11,000 to $41,000 in US hospitals. But in fact, American doctors routinely prescribe medical treatments that are not based on sound science. The stent controversy serves as a reminder that the United States struggles when it comes to winnowing evidence-based treatments from the ineffective chaff.
(Associated Press) – After decades of hope and high promise, this was the year scientists really showed they could doctor DNA to successfully treat diseases. Gene therapies to treat cancer and even pull off the biblical-sounding feat of helping the blind to see were approved by U.S. regulators, establishing gene manipulation as a new mode of medicine. Almost 20 years ago, a teen’s death in a gene experiment put a chill on what had been a field full of outsized expectations. Now, a series of jaw-dropping successes have renewed hopes that some one-time fixes of DNA, the chemical code that governs life, might turn out to be cures.
(Reuters) – [Warning: Graphic Images] Federal agents discovered four preserved fetuses in the Detroit warehouse of a man who sold human body parts, confidential photographs reviewed by Reuters show. The fetuses were found during a December 2013 raid of businessman Arthur Rathburn’s warehouse. The fetuses, which appear to have been in their second trimester, were submerged in a liquid that included human brain tissue. Rathburn, a former body broker, is accused of defrauding customers by sending them diseased body parts. He has pleaded not guilty and his trial is set for January.
(CNN) – The pup was cloned from Apple, a different dog whose genome was edited to develop the disease atherosclerosis. With that genetic information now coded in, the disease — a leading cause of stroke and heart sickness — was passed along to Longlong, who scientists will use to study the condition and its possible cures. Longlong’s creator, Beijing-based biotech company Sinogene, said Longlong is the world’s first dog cloned from a gene-edited donor.
Qualitative Health Research (vol. 27, no. 13, 2017) is available online by subscription only.
- “Nurses as Antibiotic Brokers: Institutionalized Praxis in the Hospital” by Alex Broom, Jennifer Broom, Emma Kirby, and Graham Scambler
- “Myth, Manners, and Medical Ritual: Defensive Medicine and the Fetish of Antibiotics” by Alex Broom et al.
- “Struggles Over Antibiotics: Physicians’ Stance-Taking Toward a Nonconforming Policy in an Intensive Care Unit” by Letizia Caronia and Marzia Saglietti
- “Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists” by Molly M. Lynch et al.
Bioethics (vol. 31, no. 9, 2017) is available online by subscription only.
- “Scanning the Body, Sequencing the Genome: Dealing with Unsolicited Findings” by Roel H. P. Wouters, Candice Cornelis, Ainsley J. Newson, Eline M. Bunnik, and Annelien L. Bredenoord
- “A Prospectus for Ethical Analysis of Ageing Individuals’ Responsibility to Prevent Cognitive Decline” by Cynthia Forlini and Wayne Hall
- “Two Kinds of Physician-Assisted Death” by Govert den Hartogh
- “The Indispensability of Labelled Groups to Vulnerability in Bioethics” by Adrian Kwek
- “A Kantian Ethics Approach to Moral Bioenhancement” by Sarah Carter
- “Moral Bioenhancement and Agential Risks: Good and Bad Outcomes” by Phil Torres
- “Ectogenesis, Abortion and a Right to the Death of the Fetus” by Joona Räsänen
- “When Doctors Deny Drugs: Sexism and Contraception Access in the Medical Field” by J. B. Delston
- “Presuming Patient Autonomy in the Face of Therapeutic Misconception” by Pat McConville
Science, Technology, and Human Values has new articles is available online by subscription only.
- “The “We” in the “Me”: Solidarity and Health Care in the Era of Personalized Medicine” by Barbara Prainsack
- “From “Experiments of Concern” to “Groups of Concern”: Constructing and Containing Citizens in Synthetic Biology” by Bronwyn Parry
- “A “We” Problem for Bioethics and the Social Sciences: A Response to Barbara Prainsack” by Bob Simpson
- “Regenerative Bodies” by Michael Fisch
Christian Bioethics (vol. 23, no. 3, 2017) is available online by subscription only.
- “Created in the Image of God: Bioethical Implications of the Imago Dei” by Mark J Cherry
- Radical Dependence and the Imago Dei: Bioethical Implications of Access to Healthcare for People with Disabilities” by Mary Jo Iozzio
- The Image of God, the Need for God, and Bioethics” by John F Kilner
- John Kilner’s Understanding of The Imago Dei and The Ethical Treatment of Persons with Disabilities” by Brad F Mellon
- Putting Image into Practice: Imago Dei, Dignity, and Their Bioethical Import” by Bryan C Pilkington
- The Image of God and Human Dignity: A Complex Conversation” by Andrew Lustig
(Undark Magazine) – Then, in late 1970, three years after the drug theory was dismissed, a pharmacologist made a forehead-slapping discovery. The two presumably different antibiotics, it turned out, were simply different brand names for clioquinol, a drug used to treat amoebic dysentery. The green hairy tongue and green urine, it turned out, had been caused by the breakdown of clioquinol in the patients’ systems. One month after the discovery, Japan banned clioquinol, and the SMON epidemic — one of the largest drug disasters in history — came to an abrupt end.
(Sydney Morning Herald) – Gammy, who has Down Syndrome, was near-death when his sister was taken more than 5000 kilometres away to a remote Western Australian town only weeks after their births in a public hospital in Bangkok on December 23, 2013. He has never seen his twin. Chanbua, who is known as Goy, last year wrote a letter to the twins’ biological Australian father David Farnell, a 59 year-old convicted sex offender, and his 51 year-old wife Wendy, pleading for them to allow her and Gammy to be reunited with Pipah, the name the Farnells gave the girl.
(WFAA) – The baby was diagnosed with a congenital heart defect called hypoplastic left heart syndrome, or HLHS, 16 weeks into pregnancy. His biological parents demanded an abortion. The surrogate, refused, saying doctors told her the condition was treatable and never recommended an abortion. “Texas law says that it’s the decision of the surrogate to make all health care decisions for the child while carrying child,” said Turner. “The [surrogacy] agreement confirms that.”
(Reuters) – Light massage can reduce pain, anxiety and the need for opioid medication in terminally ill patients, a Swedish study suggests. “All end-of-life patients experience existential pain or existential suffering,” coauthor Linda Bjorkhem-Bergman told Reuters Health. “This pain is difficult to treat pharmacologically and complementary methods, such as massage, provide an alternative.”
(NBC News) – Ohio is prohibiting doctors from performing abortions based on a diagnosis of Down syndrome, joining other states with similarly strict legislation. Republican Gov. John Kasich signed the legislation into law on Friday. Lawmakers had sent the bill to him earlier this month, in one of their last acts of the year.